Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2021
SEEDS and Eagle Pharmaceuticals announce multi-year partnership
SEEDS announced a multi-year partnership with Eagle Pharmaceuticals to provide educational funding for 12 high-achieving students over two years and support existing students in SEEDS' Scholars programs.
2020
FDA grants final approval for Pemfexy
The FDA approved Eagle Pharmaceuticals’ Pemfexy for advanced cases of non-small cell lung cancer. Eagle’s CEO said the company had received final approval.